2026 Edgar G. Engleman: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	111	472	437	288	262	389	46258
Medicine	111	5327	5002	2877	2668	404	46350

Overview

Edgar G. Engleman is affiliated with Stanford University in the United States. Their research spans several interconnected fields, primarily within immunology, microbiology, and medicine. The work focuses extensively on cancer immunotherapy, immune responses, and molecular biology.

The main fields of study for Engleman include:

Immunology and Microbiology
Medicine
Biochemistry, Genetics and Molecular Biology

Within these fields, Engleman's research covers various subfields such as:

Immunology
Oncology
Molecular Biology
Cell Biology
Hematology

The primary topics of Engleman's scientific contributions involve:

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Immune cells in cancer
Immune Cell Function and Interaction
Single-cell and spatial transcriptomics
Glycosylation and Glycoproteins Research

Engleman has contributed to multiple research publications with notable recent papers including:

"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" (2020) published in Annual Review of Pathology Mechanisms of Disease
"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis" (2022) published in Cell
"Mechanical Stiffness Controls Dendritic Cell Metabolism and Function" (2021) published in Cell Reports
"Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity" (2020) published in Nature Cancer
"Neutrophil-activating therapy for the treatment of cancer" (2023) published in Cancer Cell

Frequent collaborators in Engleman's research include:

Nathan E. Reticker-Flynn
Weiruo Zhang
Sylvia K. Plevritis
John B. Sunwoo
Andrew J. Gentles

Engleman's research is often published in these venues:

Cancer Research
bioRxiv (Cold Spring Harbor Laboratory)
Regular and Young Investigator Award Abstracts
Nature
International Journal of Molecular Sciences

Best Publications

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

Frank J. Hsu;Claudia Benike;Francesco Fagnoni;Tina Marie Liles

2447
Citations
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.

Sreya Bagchi;Robert Yuan;Edgar G Engleman

2056
Citations
Normalization of obesity-associated insulin resistance through immunotherapy.

Shawn Winer;Yin Chan;Geoffrey Paltser;Dorothy Truong

1604
Citations
Langerhans cells renew in the skin throughout life under steady-state conditions

Miriam Merad;Markus G. Manz;Holger Karsunky;Amy Wagers

1230
Citations
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

Lawrence Fong;Yafei Hou;Alberto Rivas;Claudia Benike

1204
Citations
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

Daniel A Winer;Shawn Winer;Shawn Winer;Lei Shen;Persis P Wadia

1189
Citations
Dendritic Cells in Cancer Immunotherapy

Lawrence Fong;Edgar G. Engleman

995
Citations
Systemic Immunity Is Required for Effective Cancer Immunotherapy

Matthew H. Spitzer;Yaron Carmi;Yaron Carmi;Nathan E. Reticker-Flynn;Serena S. Kwek

968
Citations
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

Barry S. Stein;Barry S. Stein;Shantharaj D. Gowda;Shantharaj D. Gowda;Jeffrey D. Lifson;Jeffrey D. Lifson;Jeffrey D. Lifson;Robert C. Penhallow

890
Citations
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Jeffrey D. Lifson;Jeffrey D. Lifson;Mark B. Feinberg;Gregory R. Reyes;Linda Rabin

779
Citations
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

Jeffrey D. Lifson;Jeffrey D. Lifson;Gregory R. Reyes;Michael S. McGrath;Barry S. Stein;Barry S. Stein

739
Citations
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

John M. Timmerman;Debra K. Czerwinski;Thomas A. Davis;Frank J. Hsu

737
Citations
Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

John D. Scandling;Stephan Busque;Sussan Dejbakhsh-Jones;Claudia Benike

604
Citations
Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor

David Traver;Koichi Akashi;Markus Manz;Miriam Merad

583
Citations
Langerhans cells renew in the skin throughout life under steady-state conditions

Unknown

529
Citations
Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility Study

Volker L. Reichardt;Craig Y. Okada;Arcangelo Liso;Claudia J. Benike

527
Citations
Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

Alexander Filatenkov;Jeanette Baker;Antonia M.S. Mueller;Justin Kenkel

502
Citations
Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients

Lawrence Fong;Dirk Brockstedt;Claudia Benike;Lijun Wu

492
Citations
Role of innate and adaptive immunity in obesity-associated metabolic disease

Tracey McLaughlin;Shelley E. Ackerman;Lei Shen;Edgar Engleman

492
Citations
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

Miriam Merad;Petra Hoffmann;Petra Hoffmann;Erik Ranheim;Sarah Slaymaker

458
Citations
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody

E G Engleman;R Warnke;R I Fox;J Dilley

449
Citations

Frequent Co-Authors

Samuel Strober Stanford University

Miriam Merad Icahn School of Medicine at Mount Sinai

Steven K. H. Foung Stanford University

F. Carl Grumet Stanford University

Lawrence Fong University of California, San Francisco

Ronald Levy Stanford University

Richard T. Hoppe Stanford University

Judith A. Shizuru Stanford University

Garry P. Nolan Stanford University

Markus G. Manz University of Zurich

External Links

Personal website of Edgar G. Engleman

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare careers can provide diverse opportunities. Nursing pathways such as Licensed Practical Nurse (LPN) programs offer an accessible entry point to patient care. Many aspiring nurses seek out easy admission LPN programs to begin their education without extensive barriers, making it a practical choice for career changers or those new to healthcare.

For advanced practice roles, becoming a Nurse Practitioner (NP) is a common goal. Programs classified under easy nurse practitioner programs to get into provide flexible admission standards, helping more students progress quickly into specialized nursing fields.

Among NP specialties, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are particularly relevant for those focusing on neuroimmune and mental health intersections. The top online PMHNP programs not only offer quality education but also ensure strong clinical placement rates, which are crucial for hands-on experience in mental health care.

Cost is another important factor for many students. Choosing from the cheapest online PMHNP certificate programs can make advanced training more accessible, helping professionals further their careers without overwhelming debt. Together, these education pathways complement Immunology studies, opening doors to impactful healthcare professions.